Controlled Substance Regulation Guide: Ambulatory Surgery Centers (ASCs)

A comprehensive guide to help you navigate DEA compliance requirements for your Ambulatory Surgery Center.

Ambulatory Surgery Centers (ASCs) play a crucial role in the healthcare ecosystem offering affordable high-quality, affordable surgical services. Nearly every ASC utilizes Controlled Substances (Narcotics) for pain management and anesthesia. Unfortunately, these powerful and addictive narcotic drugs are at high risk of being misused or even stolen (diverted) by patients and staff of ASCs. To ensure safety, ASCs must comply with various regulations enforced by the Drug Enforcement Agency (DEA) that focus on the proper handling and management of controlled substances. A comprehensive guide for ASC leaders to follow can be found below:

DEA Registration

When starting up, ASCs must register a new facility with the DEA by submitting an application (DEA Form 224) and paying the $888 required fee. It is important to keep your ASCs DEA registration current, by renewing your ASCs registration every three years by filing Form 224A with the agency. Failure to register or keep registration current can lead to severe penalties.

Secure Storage Protocols

Controlled substances should be stored in securely locked cabinets (such as a MedServe), constructed to withstand unauthorized access. Additionally, the storage area must be strategically located to minimize the risks of theft or diversion.

Accurate Recordkeeping and Reporting

ASCs must maintain meticulous records of all controlled substances received, stored, and dispensed. These records should be readily available for inspection by DEA officials and kept for a minimum of two years. MedServe automatically creates tamper-proof DEA logs that can be stored for a minimum of two years in our secure cloud. In the event any diversion, theft, or significant loss of Controlled substances occurs at your ASC, you must report the event to the DEA by filing Form 106 no later than one business day after the event is discovered. In the event your facility is audited by the DEA, your facility can be fined for failing to properly record transactions properly.

Enhanced Security Measures

To combat the diversion or illicit use of controlled substances, ASCs are expected to implement robust security measures. This includes installing secure storage tracking solutions (such as MedServe), alarm systems, surveillance cameras, and proper lighting, as well as conducting medication inventory accounts.

Employee Screening and Training

ASCs must screen employees who will have access to controlled substances, ensuring their reliability and integrity. Adequate training on DEA regulations, as well as the facility's policies and procedures, should be provided to all relevant personnel.

Efficient Waste Disposal Practices

In addition to secure storage and meticulous recordkeeping, ASCs must also implement efficient waste disposal practices for controlled substances. Proper disposal ensures that unused or expired medications are not left vulnerable to diversion or misuse. ASCs should establish protocols for the disposal of controlled substances in compliance with DEA guidelines, which may include utilizing registered reverse distributors or DEA-authorized collectors for destruction.

Continual Staff Education and Monitoring

Continuous education and monitoring of staff members are essential components of maintaining DEA compliance within ASCs. Regular training sessions should be conducted to update employees on evolving regulations, best practices for controlled substance management, and identifying potential signs of diversion or misuse. Additionally, implementing routine audits and internal checks can help identify any discrepancies in recordkeeping or suspicious behavior among staff members.

Integration of Technology Solutions

ASCs can leverage technology solutions to streamline compliance efforts and enhance security measures. Implementing automated inventory management systems can facilitate accurate recordkeeping and real-time tracking of controlled substances, reducing the risk of errors or discrepancies. Furthermore, integrating electronic prescribing systems can help mitigate the potential for prescription forgery or unauthorized access to prescription pads, thereby enhancing overall medication security within the facility.

Collaboration with Law Enforcement and Regulatory Agencies

Maintaining open lines of communication with local law enforcement agencies and regulatory bodies is crucial for ASCs to stay informed about emerging threats or regulatory changes related to controlled substances. Establishing partnerships with these entities can facilitate information sharing, provide access to resources for combating diversion, and demonstrate a commitment to proactive compliance within the healthcare community.

Community Outreach and Education Initiatives

ASCs can also play a proactive role in addressing substance misuse within their communities through outreach and education initiatives. Hosting informational sessions or participating in community events can help raise awareness about the risks associated with controlled substances and promote responsible medication use. By fostering dialogue and collaboration with patients, caregivers, and other stakeholders, ASCs can contribute to broader efforts to combat substance abuse and promote public health and safety.

Concluding Thoughts

Compliance with DEA regulations is paramount for ASCs to ensure the secure and safe handling of controlled substances. Failure to comply may result in severe consequences, such as fines, loss of DEA registration, and potential legal ramifications. In addition to DEA regulations, ASCs should also understand and adhere to specific state and local regulations concerning controlled substance security, as these requirements can vary. Consulting with regulatory experts is highly recommended to guarantee full compliance with all applicable laws and optimize your ASC's operations.

For expert advice and a personalized assessment of your ASC's controlled substance compliance practices, and to see MedServe’s modern narcotic management solution purpose-built for ASCs in action, please book a demo.

Previous
Previous

Missing fentanyl leads to license suspension at Wyoming ASC…

Next
Next

How to Report a Significant Loss or Theft of Controlled Substances with DEA Form 106